MoonLake Immunotherapeutics - 53 Year Dividend History | MLTX

Historical dividend payout and yield for MoonLake Immunotherapeutics (MLTX) since 1971. The current TTM dividend payout for MoonLake Immunotherapeutics (MLTX) as of May 17, 2024 is $0.00. The current dividend yield for MoonLake Immunotherapeutics as of May 17, 2024 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $2.610B $0.000B
MoonLake Immunotherapeutics AG is a clinical-stage biotechnology company. It focused on creating next-level therapies for inflammatory skin and joint diseases. MoonLake Immunotherapeutics AG, formerly known as Helix Acquisition Corp., is based in BOSTON.
Stock Name Country Market Cap PE Ratio